These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33446983)

  • 1. Intravenous Immunoglobulin may Reverse Multisystem Inflammation in COVID-19 Pneumonitis and Guillain-Barré Syndrome.
    Chakraborty N; Kumar H
    Indian J Crit Care Med; 2020 Dec; 24(12):1264-1268. PubMed ID: 33446983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell's Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin.
    Khaja M; Gomez GPR; Santana Y; Hernandez N; Haider A; Lara JLP; Elkin R
    Am J Case Rep; 2020 Oct; 21():e927956. PubMed ID: 33128540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Guillain-Barré Syndrome Associated With COVID-19.
    Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Guillain-Barre Syndrome With COVID-19: A Case Report and Literature Review.
    Singh R; Shiza ST; Saadat R; Dawe M; Rehman U
    Cureus; 2021 Mar; 13(3):e13828. PubMed ID: 33854850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré Syndrome in an Elderly Patient as a Complication of COVID-19 Infection.
    Miyajan KF; Alyamani NA; Zafer DO; Tawakul AA
    Cureus; 2021 Oct; 13(10):e19154. PubMed ID: 34868787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré Syndrome Associated with COVID-19 in a Japanese Male.
    Esa Y; Kajiyama Y; Kaido M; Watanabe Y; Fujimura H; Gohma I; Takahashi K; Kobayashi J
    Case Rep Neurol Med; 2022; 2022():6837851. PubMed ID: 36316995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré Syndrome associated with SARS-CoV-2 infection in Nepal: A case report.
    Sharma S; Adhikari A; Ghimire N; Mainali G; Yadav SK; Rajkarnikar R
    Ann Med Surg (Lond); 2022 Aug; 80():104214. PubMed ID: 35936572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.
    Sancho-Saldaña A; Lambea-Gil Á; Liesa JLC; Caballo MRB; Garay MH; Celada DR; Serrano-Ponz M
    Clin Med (Lond); 2020 Jul; 20(4):e93-e94. PubMed ID: 32518103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of IV Immunoglobulin in Indian Children With Guillain-Barré Syndrome.
    Kalita J; Kumar M; Misra UK
    Pediatr Crit Care Med; 2019 Jul; 20(7):652-659. PubMed ID: 30985608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute inflammatory demyelinating polyneuropathy or Guillain-Barré syndrome associated with COVID-19: a case report.
    Gagarkin DA; Dombrowski KE; Thakar KB; DePetrillo JC
    J Med Case Rep; 2021 Apr; 15(1):219. PubMed ID: 33910640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review.
    Agosti E; Giorgianni A; D'Amore F; Vinacci G; Balbi S; Locatelli D
    Neurol Sci; 2021 Feb; 42(2):607-612. PubMed ID: 32643136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19-associated Severe Multisystem Inflammatory Syndrome in Children with Encephalopathy and Neuropathy in an Adolescent Girl with the Successful Outcome: An Unusual Presentation.
    Mehra B; Aggarwal V; Kumar P; Kundal M; Gupta D; Kumar A; Dugaya SK
    Indian J Crit Care Med; 2020 Dec; 24(12):1276-1278. PubMed ID: 33446986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-Onset Guillain-Barré Syndrome and Right Facial Nerve Palsy after COVID-19 Infection.
    Taguchi M; Bonner K; Memon AB
    Case Rep Neurol; 2022; 14(1):12-18. PubMed ID: 35111031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over intravenous immunoglobulin.
    Buzzigoli SB; Genovesi M; Lambelet P; Logi C; Raffaelli S; Cattano D
    Anaesth Intensive Care; 2010 Mar; 38(2):387-9. PubMed ID: 20369779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication.
    Chakraborty U; Hati A; Chandra A
    Diabetes Metab Syndr; 2021; 15(6):102326. PubMed ID: 34731822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.
    Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A
    Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Looks Like Neurosyphilis, Feels Like Guillain-Barre: At the Confluence of Infection and Immunology.
    Berger JI; Vernon K; Abdo F; Gulati S; Hariharan R
    Cureus; 2022 Jun; 14(6):e26318. PubMed ID: 35911366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: Guillain-Barré Syndrome Associated With COVID-19.
    Khedr EM; Shoyb A; Mohamed KO; Karim AA; Saber M
    Front Neurol; 2021; 12():678136. PubMed ID: 34239495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome with associated unilateral ptosis without ophthalmoplegia - a rare presentation: a case report and review of the literature.
    Ralapanawa U; Kumarihamy P; Jayalath T; Udupihille J
    J Med Case Rep; 2019 Jul; 13(1):221. PubMed ID: 31324211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.